ACA

NEUTRALM&A

Arcosa, Inc.

2026-10-22

Price

$149.15

+0.08%

This is the 2026-10-22 snapshot — the signals and analysis for ACA as of this single trading day.

View full ACA research hub →

Score6.5Priority

Signals4/8 DNA1/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume1.4xvs 20d avg

Analysis

Arcosa (ACA) is currently trading in a textbook merger arbitrage pattern following the announcement of its all-cash acquisition by CRH for $150 per share. The technical signals—PERFECT_STACK and QUIET_ACCUMULATION—combined with exceptionally low realized volatility (4.5%) reflect institutional capital parking in the stock as it awaits final regulatory clearance. While the broader macro regime is RISK_ON and shrugging off bearish noise, ACA's price action is entirely insulated by the definitive deal terms, making it a pure play on deal completion rather than market beta.

Fired Signals

ALPHA MALEGOLDEN CROSSMARKET LEADERPERFECT STACKQUIET ACCUMULATIONWEAK FINISH

Key Takeaways

The primary driver is the pending all-cash acquisition by CRH at $150 per share, capping upside but providing a hard fundamental floor.
Technical strength and ultra-low volatility indicate high institutional confidence in the deal closing, keeping the stock tightly pinned near the buyout price.
Upcoming Q3 earnings on October 29 will likely be a non-event, as Arcosa has suspended financial guidance due to the impending merger.

← Back to 2026-10-22 View Full ACA History →Yahoo Finance &nearr;